ZA201004219B
(en )
2013-02-27
Dr6 antibodies inhibiting the binding of dr6 to app,and uses thereof in treating neurological disorders
EP2170309A4
(en )
2010-11-03
Methods and compositions for treating disorders
GB201001047D0
(en )
2010-03-10
Methods and compositions for the treatment of neurological disorders
WO2009052431A3
(en )
2010-01-14
Cd19 binding agents and uses thereof
HK1224213A1
(en )
2017-08-18
Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) (pml)
HUE039108T2
(en )
2018-12-28
Compositions and methods for treating ophthalmic disorders
EP2152266A4
(en )
2010-07-28
Compositions and methods for treating disorders associated with salt or fluid retention
ZA201001789B
(en )
2011-12-28
Composition and methods for use for antibodies against sclerostin
IL205279A0
(en )
2011-07-31
Methods of treating urogenital - neurological disorders using modified clostridial toxins
ZA200610661B
(en )
2008-08-27
Compositions and methods for treating neurological disorders
EP2041180A4
(en )
2010-05-05
Ilt3 binding molecules and uses therefor
IL208518A
(en )
2017-02-28
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
GB2466912B
(en )
2012-01-04
Compositions and methods for treating lysosomal disorders
HK1157575A1
(en )
2012-07-06
Treating neurological disorders
IL202424A
(en )
2017-01-31
Telomerase activating compounds for use in treating diseases, disorders and conditions related thereto
ZA201003497B
(en )
2011-02-23
Methods for treating obesity and obesity related diseases and disorders
GB2467710B
(en )
2013-02-20
Methods for treating social disorders
EP2205255A4
(en )
2012-02-29
Herbal compositions and methods for treating hepatitic disorders
HK1118716A1
(en )
2009-02-20
Method and composition for treating central nervous system disorders
IL193697A0
(en )
2009-08-03
Methods for treating cognitive and other disorders
EP2120994A4
(en )
2011-09-28
Methods and compositions for treating hypoglycemic disorders
GB2465814B
(en )
2011-10-26
Method,composition and device for the treatment of enzymes and saccharides disorders
IL196561A0
(en )
2009-11-18
Compositions and methods for treating diabetes and neuropsychological dysfunction
EP1898921A4
(en )
2008-11-05
Compositions and methods for treating sleep disorders
ZA200904323B
(en )
2010-08-25
DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders